Search

everythinglearnresearchcommunity

for

Search:↓

Blocking JAK/STAT pathways can help treat hair loss from alopecia areata.

Tofacitinib may help treat severe childhood alopecia areata, but risks require careful consideration.

Some patients with mycosis fungoides or Sézary syndrome experience hair loss, which may be similar to alopecia areata or linked to skin lesions, possibly due to abnormal T cells, and bexarotene can help treat it.

Alopecia is linked to various health and mental conditions, impacts life quality, and needs medical attention beyond its cosmetic effects.

Bimatoprost was found to be safer and more effective than mometasone furoate for treating scalp hair loss.

Dilated follicular infundibula and increased catagen/telogen follicles are key indicators for diagnosing alopecia areata.

Alefacept showed some effectiveness for alopecia areata but needs more research.

Bimatoprost is safe but not effective for severe eyelash loss from alopecia areata, possibly helping those with less loss.

Older age at onset of alopecia areata leads to less severe and shorter episodes, with most patients experiencing significant hair regrowth.

Alopecia areata is an autoimmune hair loss condition treated with corticosteroids, and histologic confirmation is the best diagnosis method.

Monochromatic light devices, especially the 308-nm excimer laser, are promising for treating alopecia areata but more research is needed.

Taking zinc supplements can help improve or cure hair loss caused by zinc deficiency.

Photodynamic therapy with methyl 5-aminolevulinic acid is ineffective for treating alopecia totalis.

Diphencyprone treatment increases CD8 lymphocytes in the scalp, which is associated with hair regrowth in alopecia areata patients.

Certain scalp patterns can indicate the severity and activity of hair loss in Turkish alopecia patients.

Patients with rapidly progressive alopecia areata often have a better outlook and shorter disease duration, with regrown fine hairs and no past alopecia being positive signs.

Baricitinib helped a woman with severe hair loss regrow almost all her hair without side effects.

The document concludes that understanding hair follicles requires more research using computational methods and an integrative approach, considering the current limitations in hair treatment products.

Alopecia areata significantly lowers quality of life, especially in personal and social areas, and more so if the patient is also depressed.

Platelet-rich plasma (PRP) is a safe and potentially effective way to treat hair loss, especially when combined with minoxidil.

1% anthralin ointment is effective and safe for treating severe alopecia areata in children.

The document concludes that ongoing research using animal models is crucial for better understanding and treating Alopecia Areata.

Tofacitinib and oral minoxidil together effectively regrow hair in severe alopecia areata patients.

Both androgenetic alopecia and alopecia areata negatively impact quality of life, with no significant difference between them.

Genetic discoveries are key for understanding, diagnosing, and treating inherited hair and nail disorders.

Alopecia areata involves immune response and gene changes affecting hair loss.

Hair loss is often linked to thyroid problems, especially in women and older people, and screening for thyroid issues is advised for those with hair loss.

The study concluded that yellow dots are a common and useful sign for diagnosing alopecia areata in dark-skinned individuals and may indicate the severity of the condition.

Late-onset alopecia areata in Taiwanese patients is more common in women, usually starts at age 57, often involves less than 10% hair loss, and may have a minimal link to thyroid issues.

The research suggests that autophagy-related genes might play a role in causing alopecia areata.